Andrade Robert 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
Andrade Robert
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common shares
2026-01-07$2.45/sh+14,184$34,751→ 191,100 total - Exercise/Conversion
Stock Options
2026-01-07$2.45/sh−14,184$34,751→ 836,567 totalExercise: $2.45From: 2016-07-05Exp: 2026-07-05→ Options (14,184 underlying)
Footnotes (1)
- [F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.